peutic agents that have been advocated in the treat ment of cerebral infarction, there are only a few clinical studies [e.g., using nimodipine (Gelmers et aI., 1988) and thrombolytic agents (Sloan, 1987) ] that have provided conclusive evidence of their ef ficacy. There are many methodological reasons for this, which is why emphasis has been placed on an imal models of human cerebrovascular disease. Rather unexpectedly, however, animal models using a wide variety of agents, some of which lyse thrombo-emboli to improve blood flow or reduce platelet "stickiness," while others depress the me tabolism of neurons, scavenge for free radicals, or act as channel blockers, have not provided the an ticipated evidence of efficacy. Yet because of in creasing clinical need, the therapeutic potential of a number of agents, such as calcium channel blockers (Mohamed et aI., 1985; Hakim, 1986; Ger mano et aI., 1987) and N-methyl-D-aspartate re ceptor antagonists (Duverger et aI., 1987; Oyzurt et aI., 1988) , needs to be subjected to rigorous evalua tion in carefully controlled laboratory conditions. Previous laboratory work has been spent on pio neering and developing models of "stroke" with the express aim of achieving a more full under standing of its pathophysiology. This has spawned the development of a plethora of experimental models in numerous species of animals of hypoxic brain damage in its various forms, viz. global and focal (regional), complete and incomplete, and per manent and transient (Garcia, 1984) . There is now therefore considerable knowledge and insight con cerning tissue responses (functional, electrophysio logical, water content, and histological) that have been found to mimic the highly variable clinical sit uation. Indeed, further information about patterns will undoubtedly be obtained from the modern neuroimaging techniques of magnetic resonance imaging (NMI), single photon emission computed tomography (SPECT), and positron emission to mography (PET).
Even though it is encouraging that so much time and effort has and is being devoted to the study of ischaemic "stroke," it is perhaps surprising that the various models have not provided answers to many of the basic questions. The reasons are prob ably threefold. First, there is considerable doubt about the relevance of many of the models to human ischaemic "stroke," second there is uncer tainty about the significance of the many param eters by which an assessment is made of brain pro tection, and third there is considerable variability in the amount of ischaemic damage produced in the various experimental models (Garcia, 1984) . Clinical experience clearly indicates that the most appropriate model is one in which there is oc clusion of a stem or branch of a major cerebral ar tery. Indeed occlusion of an intracranial artery, usually the middle cerebral artery, has been widely used to produce focal ischaemic damage in large animals, such as the cat (Sundt and Waltz, 1966) , dog (Harvey and Rasmussen, 195 1; Suzuki et al., 1980) and the nonhuman primate (Meyer and Denny-Brown, 1957; Hudgins and Garcia, 1970) . These authors suggest that even though there is some variation in size and distribution, a reproduc ible lesion results if the artery is occluded at a proximal site and cardiorespiratory status is rigor ously controlled. In contrast, the design of a repro ducible model of focal ischaemia in the rodent has proved difficult. After an extracranial artery is oc cluded, the efficiency of the intracranial collateral circulation usually prevents the development of brain damage unless an additional stress such as hypoxia or hypotension is added, or unless there is a preexisting vascular anomaly or hypertension. These stresses, however, can introduce important complicating factors, and the lesions that result are commonly variable. Even though these various models had their counterpart in clinical practice, the lack of reproducibility made them unsuitable for testing potential therapies. In spite of these models, methods that use either surgical or mechanical oc clusion of vessels are to be preferred to models of embolism that give rise to focal cerebral ischaemia of variable onset and distribution.
More recently, relatively cheap, small animal models of focal cerebral ischaemia produced by distal occlusion of the middle cerebral artery have been described (Robinson, 198 1; Coyle, 1982) , but in both of these instances there is sparing of the striatum and only a small variable lesion in the frontoparietal cortex. In contrast, occlusion of the proximal middle cerebral artery in the rat (Al banese et al., 1980; Ta mura et al., 198 1; Nakayama et al., 1988) results in a lesion affecting both cortex and striatum that is reproducible and with suffi- 1988 ciently well-defined end-points to allow investiga tion of the pathophysiology of ischaemia using au toradiographic and neurochemical techniques and, more recently, an objective assessment of the influ ence of drug treatments on pathophysiological mechanisms.
Even though neurological deficit, cerebral blood flow, glycolytic metabolism, water content, or elec trocortical activity have been used as parameters of cerebral protection (MacKenzie et al., 1986) , there is an increasing appreciation of the importance of quantitative histological studies as a measure of the putative anti-ischaemic effects of therapeutic agents. Rarely, however, has it been possible to make confident statements about the size of the le sion when comparing untreated and drug-treated animals. With increasing experience and modifica tion (Bederson et aI., 1986) of the original technique described by Ta mura et al. (198 1), a method for the volumetric assessment of early cerebral infarction together with statistical and biological validation has now been described in the rat (Osborne et al., 1987) and also in the cat (Gotti et al., 1984) . Never theless, in the rat, for example, there is variability of infarct volume, particularly of the cortex after oc clusion of the proximal segment of the middle cere bral artery and the lenticulostriate arteries with a range of between 26 ± 6 mm3 (Mohamed et al., 1985) and 50 ± 4 mm3 (Osborne et al., 1987) from the same laboratory. Given the descriptions of these protocols, it could have been reasonably pre sumed that certain methodologies had been estab lished that could accurately measure the volume of cerebral infarction in reproducible models, thus al lowing the objective investigation of the beneficial or detrimental effects of various influences on the volume of the focal ischaemic brain damage.
Two recent articles in this Journal (Brint et aI., 1988; Duverger and MacKenzie, 1988) address these important issues and provide considerable in sight into the large number of factors that need to be considered when trying to establish a model of focal cerebral ischaemia that is reproducible and suitable for the evaluation of potential drug ther apies. Both articles need to be read carefully. Brint et al. (1988) detail a 3-year longitudinal experience using three strains of rat (Wi star, Fischer 344, and spontaneously hypertensive). The focal ischaemic damage was produced by concurrent permanent occlusion of the distal middle cerebral and the common carotid arteries, and its volume was calcu lated by integration of areas of infarction identified on frozen sections stained by haematoxylin and eosin using an image analyser. The authors show that the largest and most reproducible cortical in-farct was found in the spontaneously hyertensive rat (SHR). Using statistical power analysis to project the number of animals to detect a 25% or 50% change in infarct volume, it was concluded that the only practical model of focal cerebral in farction was that using SHR when n = 10 animals per group. Use of either of the other two strains would require much larger numbers of animals to achieve any statistical difference between control and test groups. U sing a model of focal cerebral ischaemia pro duced by occlusion of the proximal middle cerebral artery in five strains of rat (Wistar/Kyoto, Sprague Dawley, Fischer 344, normotensive SHR, and stroke-prone SHR) Duverger and MacKenzie (1988) found that in spite of identical animal house facilities, anaesthesia, and surgical technique, there was considerable variation in the different strains in the amount of ischaemic damage found after a sur vival of 2 days as calculated from paraffin sections using integration of areas drawn and measured at eight levels by planimetry. There was only a small lesion, for example, in the Wistar/Kyoto strain, a larger lesion in the Sprague Dawley, and an even larger though variable lesion in Fischer 344. The biggest infarcts, however, were found in the SHR strains. Based on this experience, these authors recommend using normotensive Fischer 344.
Reasons for the variability were investigated. One factor was thought to be the vascular anatomy of the circle of Willis, as it is known both in humans (Alpers et aI., 1959; Riggs and Rupp, 1963) and rats (Brown, 1966) that variations are common and might well play a role in affecting the collateral cir culation. It is also well known that ischaemic stroke is age-related, being most common in the elderly (Kannel and Wolf, 1983) , possibly due to a combi nation of factors that include arteriosclerosis, ath eroma, and impaired reactivity of the cerebral cir culation. Duverger and MacKenzie (1988) , how ever, found no difference in the amount of ischaemic damage in young (3 and 9 month) and el derly (20 month) Fischer 344 rats. Further studies are clearly required. The role of hypertension is discussed in view of the well-known association with cerebrovascular disease (Gautier, 1983) . The findings of Coyle et ai. (1984) were confirmed by Duverger and MacKenzie (1988) , who found that larger infarcts could be induced in spontaneously hypertensive rats when compared with normoten sive Wi star rats. The role of diabetes mellitus was also studied by Duverger and MacKenzie (1988) , who induced experimental diabetes by the adminis tration of streptozotocin 3 days prior to middle ce rebral artery occlusion. Severe hyperglycaemia (>400 mg/dl) was associated with an increased volume of infarction in keeping with the human clinical data (Kannel and Wolf, 1983; Pulsinelli et aI., 1983) and some (Venables et aI., 1985) but not all experimental work (Nedergaard and Diemer, 1985) .
During the 3-year period of trying to establish a reproducible model of focal cerebral ischaemia in the rat, Brint et ai. (1988) identified additional vari ables that either singly or in combination could in fluence the amount of structural damage and that therefore required to be standardised. These vari ables included the supplier of the animals, the strain of rat (Coyle, 1986) , whether the colony was inbred or outbred, the age of the animals (Coyle, 1982) , the surgical skills of different individuals, and the type and dosage of anaesthesia. Physiolog ical monitoring required to be comprehensive and to include parameters such as temperature [as has been highlighted recently by Busto et ai. (1967) ), arterial blood pressure, haematocrit, blood glucose, and blood gases. These authors also draw attention to the need to standardise pathological techniques, stressing that perfusion fixation is required for the identification of early ischaemic damage (Brown and Brierley, 1972) and its separation from the arte fact dark cell change (Cammermeyer, 196 1; Brown, 1977) , and the need to correct for the amount of oedema. The processing cycles used for dehy drating and embedding the tissue for microscopy were also important. While early infarction can be easily identified by light microscopy in paraffin sections after perfusion fixation for the purposes of quantitation (Osborne et aI., 1987) , a longer sur vival is required for the accurate identification of focal ischaemic damage in frozen sections. The longer the survival, however, the easier the identifi cation, but the greater the possibility of postinsult complications and possible variability in the size of the ischaemic lesion. Even though the postopera tive mortality is increased, the amount of ischaemic damage calculated at 24 h is not statistically signifi cantly greater than at 6 h (Bederson et aI., 1986; Duverger et aI., 1985) . There is also a tendency for a certain percentage of the operated animals to be excluded because of intraoperative difficulties, and rarely are details provided of postoperative mor tality.
While many of these factors (and no doubt there are others such as proper design with full statistical input) have contributed to the reported variability, increasing attention is being directed to the need to define the pharmokinetics of the drug therapy under study. This is particularly important with re spect to the dose and route of administration and blood levels in relation to the onset of the ischaemic event. Another consideration is that pathophysio logical studies have shown that reversible middle cerebral artery occlusion of up to 6 h in the sub human primate is not associated with irreversible ischaemic damage, and only thereafter is the amount of infarction a function of the duration of ischaemia (Jones et aI., 198 1; Bederson et aI., 1986; Weinstein et aI., 1986) . This, together with the rec ognition of the penumbra as part of the concept of thresholds of ischaemia (Astrup et aI., 198 1; As trup, 1982) and the recognition of a window of ther apeutic opportunity, has given considerable im petus to the treatment of ischaemic stroke.
There are very few published studies that have been designed in such a way as to take into account most, if not all, of the variables that have been identified as producing variability in models of focal cerebral ischaemia. The need to do so is readily apparent as there are an increasing number of agents for the treatment of focal cerebral infarc tion that require to be assessed rigorously. This can only come about if there is an agreement con cerning guidelines for the design of such experi ments as a basis of future work so that the results from one laboratory can be reproduced in another. Perhaps the International Society of Cerebral Blood Flow and Metabolism should initiate this process. Sufficient information is now available on a whole host of factors to make this task possible. It is only by introducing some sort of standardisation and by being more critical that we can hope to more readily persuade clinicians of the efficacy of certain drug therapies in the treatment of ischaemic stroke.
